Skip to content

BDSX

Biodesix, Inc.

NASDAQ · Healthcare · Medical - Diagnostics & Research · US

$26.18
−1.11%
Ask drillr
3
Insider buys (3m)
0
Insider sells (3m)
$1.0M
Net value (3m)
+66.8%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 13, 2026SCHULER JACK W · 10 percent owner, other: Emeritus DirectorPurchase15,000$24
Aug 12, 2026SCHULER JACK W · 10 percent owner, other: Emeritus DirectorPurchase13,900$24
Aug 12, 2026SCHULER JACK W · 10 percent owner, other: Emeritus DirectorPurchase13,700$24
Jul 2, 2026PATIENCE JOHN · director, other: ChairmanM-Exempt1,361$0.00
Apr 2, 2026PATIENCE JOHN · director, other: ChairmanM-Exempt1,361$0.00
Feb 23, 2026Cowie Robin Harper · officer: CFO, Sec'y & TreasurerSale535$13
Feb 23, 2026Pestano Gary Anthony · officer: Chief Development OfficerM-Exempt1,528$0.00
Feb 23, 2026O'Kane Kieran · officer: Chief Commercial OfficerSale535$13
Feb 23, 2026Vazquez Chris · officer: Chief Accounting OfficerSale211$13
Feb 23, 2026Hutton Scott · director, officer: President & CEOM-Exempt4,844$0.00
Feb 23, 2026O'Kane Kieran · officer: Chief Commercial OfficerM-Exempt1,469$0.00
Feb 23, 2026Cowie Robin Harper · officer: CFO, Sec'y & TreasurerM-Exempt1,469$0.00
Feb 23, 2026Hutton Scott · director, officer: President & CEOSale1,490$13
Feb 23, 2026Pestano Gary Anthony · officer: Chief Development OfficerSale556$13
Feb 23, 2026Vazquez Chris · officer: Chief Accounting OfficerM-Exempt563$0.00
Feb 11, 2026Cowie Robin Harper · officer: CFO, Sec'y & TreasurerM-Exempt2,427$0.00
Feb 11, 2026Vazquez Chris · officer: Chief Accounting OfficerM-Exempt235$0.00
Feb 11, 2026Pestano Gary Anthony · officer: Chief Development OfficerSale540$10
Feb 11, 2026Cowie Robin Harper · officer: CFO, Sec'y & TreasurerM-Exempt2,584$0.00
Feb 11, 2026Vazquez Chris · officer: Chief Accounting OfficerSale101$10
Feb 11, 2026Hutton Scott · director, officer: President & CEOM-Exempt610$0.00
Feb 11, 2026Pestano Gary Anthony · officer: Chief Development OfficerM-Exempt1,481$0.00
Feb 11, 2026O'Kane Kieran · officer: Chief Commercial OfficerSale584$10
Feb 11, 2026O'Kane Kieran · officer: Chief Commercial OfficerM-Exempt1,600$0.00
Feb 11, 2026Hutton Scott · director, officer: President & CEOM-Exempt9,388$0.00
Feb 11, 2026Hutton Scott · director, officer: President & CEOSale3,559$10
Feb 11, 2026Vazquez Chris · officer: Chief Accounting OfficerM-Exempt263$0.00
Feb 11, 2026Pestano Gary Anthony · officer: Chief Development OfficerM-Exempt68$0.00
Feb 11, 2026Pestano Gary Anthony · officer: Chief Development OfficerM-Exempt1,413$0.00
Feb 11, 2026O'Kane Kieran · officer: Chief Commercial OfficerM-Exempt1,527$0.00
Institutional positioning

13F filings over the trailing two quarters

New 24Increased 7Reduced 2Sold out 39
FilerActionSharesFiled
AIGH CAPITAL MANAGEMENT LLCNew Position758,328Apr 30, 2026
TELEMARK ASSET MANAGEMENT, LLCIncreased489,824May 12, 2026
ABRDN PLCIncreased458,438Apr 29, 2026
SOLEUS CAPITAL MANAGEMENT, L.P.New Position416,599May 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position255,161May 15, 2026
OPALEYE MANAGEMENT INC.New Position238,047May 15, 2026
MARSHALL WACE, LLPNew Position141,636May 15, 2026
ESSEX INVESTMENT MANAGEMENT CO LLCNew Position132,086May 11, 2026
STEMPOINT CAPITAL LPNew Position70,004May 18, 2026
TREXQUANT INVESTMENT LPIncreased69,601May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased49,998May 15, 2026
TWO SIGMA INVESTMENTS, LPNew Position45,231May 15, 2026
PERKINS CAPITAL MANAGEMENT INCUnchanged44,783Apr 23, 2026
SEI INVESTMENTS CONew Position43,024May 13, 2026
LEGATO CAPITAL MANAGEMENT LLCNew Position41,174May 14, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 13, 2026